About akeso inc - AKESF
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. It operates through the following geographical segments: Chinese Mainland, USA, and Other Regions. The company was founded by Yu Xia, Peng Zhang, Baiyong Li, and Zhongmin Wang in March 2012 and is headquartered in Zhongshan, China.
AKESF At a Glance
Akeso, Inc.
Torch Development Zone
Zhongshan, Guangdong 528437
| Phone | N/A | Revenue | 425.16M | |
| Industry | Pharmaceuticals: Major | Net Income | -154,835,228.74 | |
| Sector | Health Technology | 2025 Sales Growth | 44.064% | |
| Fiscal Year-end | 12 / 2026 | Employees | 3,761 | |
| View SEC Filings |
AKESF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 30.83 |
| Price to Book Ratio | 10.316 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -131.288 |
| Enterprise Value to Sales | 29.242 |
| Total Debt to Enterprise Value | 0.052 |
AKESF Efficiency
| Revenue/Employee | 113,045.676 |
| Income Per Employee | -41,168.633 |
| Receivables Turnover | 2.587 |
| Total Asset Turnover | 0.211 |
AKESF Liquidity
| Current Ratio | 5.137 |
| Quick Ratio | 4.713 |
| Cash Ratio | 4.178 |
AKESF Profitability
| Gross Margin | 78.561 |
| Operating Margin | -30.842 |
| Pretax Margin | -26.70 |
| Net Margin | -36.418 |
| Return on Assets | -7.67 |
| Return on Equity | -13.897 |
| Return on Total Capital | -7.954 |
| Return on Invested Capital | -9.493 |
AKESF Capital Structure
| Total Debt to Total Equity | 50.355 |
| Total Debt to Total Capital | 33.491 |
| Total Debt to Total Assets | 28.474 |
| Long-Term Debt to Equity | 43.81 |
| Long-Term Debt to Total Capital | 29.138 |